Diseases, Conditions, Syndromes

Trudeau expects most of Canada to be vaccinated by September

Prime Minister Justin Trudeau said Friday he expects more than half of Canadians to receive a COVID-19 vaccine by next September after he came under criticism for saying Canadians won't be among the first to get doses.

Medications

Xofluza approved for postexposure prevention of flu

(HealthDay)—The approved indication for Xofluza (baloxavir marboxil) has been expanded to include postexposure prevention of influenza for those who may have come in contact with someone who has the flu, the U.S. Food and ...

Vaccination

US targets mass virus vaccine campaign by year's end

The United States hopes to begin a sweeping program of COVID vaccinations, reaching perhaps 20 million people by year's end, top public health officials said Sunday as cases surge across the worst-hit nation.

Medications

US approves Regeneron antibody treatment given to Trump

A COVID-19 antibody therapy used to treat President Donald Trump was approved by the US drug regulator on Saturday for people who aren't yet hospitalized by the disease but are at high risk.

Diseases, Conditions, Syndromes

FDA issues EUA to baricitinib plus remdesivir for COVID-19

(HealthDay)—Emergency use authorization was issued for baricitinib in combination with remdesivir for hospitalized patients with COVID-19, the U.S. Food and Drug Administration announced Thursday.

Vaccination

What we can expect from two experimental vaccines

Harvard T.H. Chan School of Public Health's Barry Bloom, Joan L. and Julius H. Jacobson Research Professor of Public Health, offers context about the news that two experimental vaccines appear to confer a high level of protection ...

Oncology & Cancer

New drug for metastatic colorectal cancer enters phase 3 trial

A new therapy for metastatic colorectal cancer that has been granted fast-track designation by the U.S. Food and Drug Administration is being tested in a phase 3 clinical trial at Vanderbilt-Ingram Cancer Center.

page 1 from 40